IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $316,000 | -4.8% | 6,273 | -4.3% | 0.06% | +19.6% |
| Q3 2017 | $332,000 | +26.7% | 6,558 | +27.1% | 0.05% | +24.4% |
| Q2 2017 | $262,000 | +25.4% | 5,158 | -0.8% | 0.04% | -10.9% |
| Q1 2017 | $209,000 | -76.9% | 5,200 | -72.6% | 0.05% | -78.7% |
| Q4 2016 | $906,000 | +84.5% | 18,958 | +41.5% | 0.22% | +51.0% |
| Q3 2016 | $491,000 | +506.2% | 13,400 | +282.9% | 0.14% | +853.3% |
| Q2 2016 | $81,000 | -31.4% | 3,500 | +84.2% | 0.02% | -65.1% |
| Q4 2015 | $118,000 | – | 1,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |